Subtypes of alpha thalassemia diagnosed at a medical center in Jordan

AMAÇ: Bu retrospektif çalışma, Ürdün’deki bir Tıp Merkezi’ndeki bir grup hastada α-Talasemi mutasyonlarını ve HbH hastalığı genotipini analiz etmektedir. YÖNTEM: Toplam 430 kişi üzerinde çalışıldı. Hb H hastalığı elektroforez, HPLC ve HbH inklüzyon cisimciklerinin supra vital boyanması ile doğrulandı. DNA analizleri; polimeraz zincir reaksiyonu, restriksiyon enzim yöntemini takiben tanı ve şüpheli α-talasemi olgularının doğrulanması için agaroz jel elektroforezi ve ters hibridizasyon analizi kullanılarak gerçekleştirildi. BULGULAR: 430 olgunun α-talasemi taşıyıcısı olduğu tepit edildi ve bu durum polimeraz zincir reaksiyonu yöntemi ile doğrulandı, beş farklı α-talasemi alt belirleyici saptandı. Otüzüç olguya HbH hastalığı tanısı kondu. SONUÇ: Bu çalışma HbH hastalarının genotiplerini ortaya koyarak hastalığın fenotipik şiddetini tahmin etmeye destek olmaktadır. Çalışma sonuçları aynı zamanda, HbH hastalığı olan kişiler için ileriye yönelik genetik danışmanlık hizmetleri amacıyla da kullanılabilir, çünkü ileri olgularda prenatal tanı gereksinimi ortaya çıkabilmektedir.

Ürdün’de bir tıp merkezinde tanı konan alfa talasemilerin alt tipleri

BACKGROUND: This retrospective analysis study provides the molecular genetics of α-Thalassemia Mutations and identify the genotype of HbH disease in a group of patients at a Medical Center in Jordan. METHODS: A total of 430 subjects were studied. HbH disease was confirmed by Electrophoresis, HPLC and the demonstration of HbH inclusion bodies by supra vital staining. DNA analysis was performed using polymerase chain reaction, restriction enzyme digestion, followed by agarose gel electrophoresis and by reverse- hybridization assay to diagnose and confirm cases suspected α-thalassemia. RESULTS: Four hundred and thirty cases were found to be α-thalassemia trait and this was confirmed by Polymerase Chain Reaction, five different α- thalassemia determinants were observed. Thirty three cases were diagnosed as HbH disease. CONCLUSION: This study helps in the prediction of the phenotype severity by identifying the genotype of HbH patients .The results of the study can be also applied for the genetic counseling to prospective patients with HbH disease, since in severe cases the need may be arise for prenatal diagnosis in population.

___

  • 1. Leukens JN, Lee GR. The Abnormal Hemoglobins. General Principles. In Wintrobe’s Clinical Hematology. 9th edition. Lea & Febiger. 1993, p. 1023-1053.
  • 2. Huisman THG, Caver MFH. The β and α-Thalassemia repository. 8th edition. Hemoglobin.1998, p. 219-236.
  • 3. Clarke GM, Higgins TN. Laboratory Investigation of Hemoglobinopathies and Thalassemias. Review and Update. Clinical Chemistry, 2000; 46(8): 1284-1290.
  • 4. Paglietti, Galanello R, Moi P, Pirastu M, Cao A. Molecular pathology of Hb H diease in Sardinians. British Journal of Haematolog. 1986; 63: 485-96.
  • 5. Weatherall PH, Clegg JB. Inherited hemoglobin disorders: an increasing global health problem. Bull WHO. 2001; 79: 704-12.
  • 6. Higgs DR, Goodboun SF, Lamb J, Clegg JB, Weatherall DJ and Proundfoot NJ. α-thalassemia caused by a polyadenylation signal mutation. Nature. 1981; 306: 398-400.
  • 7. Thein SL, Wallace RB, Pressly L, Clegg JB, Weatherall DJ and Higgs DR. The polyadenylation site mutation in the alpha-globin gene cluster. Blood. 1988; 71: 313-319.
  • 8. Fei YJ, Öner R, Bozcunt G, Gu LH, Altay C, Gürgey A, Fattoum S.Baysal E, Huisman. THJ. Hb H disease caused by homozygosity for the AATAAA> AATAAG mutation in the polyadenylation site of the α2 globin gene. Acta Haematology. 1992; 88, 82-85.
  • 9. Orkin SH, Goff SC, and Hechtman RL. Mutation in the intervening sequence splice junction in man. Proceedings of the National of Science of the United States of America. 1981; 78: 5041-5045.
  • 10. Babiker MM, Bashir N, Sarsou N. Prevalence of thalassemia in school children in north eastern Badia Jordan. East Meditarr Health. 1999; 5(6): 1165-70.
  • 11. Bashir N, Barkawi M, Sharif L, Momani A, Gharaibeh N. Prevalence of haemoglobinopathies in North Jordan. Trop Geogr Med. 1991; 44: 122-125.
  • 12. Sunna EI, Gharibeh NS, Knapp DD, Bashir NA. Prevalence of Hemoglobin S and β-Thalassemia in northern Jordan. J Obstet Gynaecol Res. 1996; 22(1):17-20.
  • 13. Liu YT, Old GM, Miles K, Fisher CA, Weatherall DJ, and Clegg JB. Rapid detection of alpha- Thalassemia deletions and alpha-globin gene triplication by multiplex polymerase chain reaction. British Journal of Haematology. 2000; 108: 295-299.
  • 14. Jassim N, AL-Arrayed S, Gerard N, Al-Mukharraq H, AL-Ajami A, Ramasawmy R, and Krishnaourty R, A Mismatched- Primer Polymerase Chain Reaction- Restriction Fragment Length Polymorphism Strategy for Rapid Screening of the Polyadenylation Signal Mutation αT-Saudi (AATAAA> AATAAG) IN THE α2 Globin Gene. Hemoglobin. 1999; 23(3): 213-220.
  • 15. Karen DF. Clinical evaluation of hemoglobinopathies: Part I. Thalassemia. The Warde Medical Laboratory Article Archives. 2003; 14 (2).
  • 16. Higgs D R, Goodburn S E Y, Lamb J, Clegg J B and weatherall DJ. alpha-Thalassemia caused by a polyadenylation signal mutation. Nature. 1983; 306:398-400.
  • 17. Cürük, MA, Kiline Y, Evrüke C, Ozgünen FT, Akosy K and Yüregir, GT. Prenatal diagnosis of Hb H disease caused by a homozygosity for the α2 polyA (AATAAA>AATAAG) mutation. Hemoglobin. 2001;25: 255-258.
  • 18. Higgs DR and Bowden DK. Molecular mechanisms of α thalassemias. In: Disorders of hemoglobin (ed. By M.H. Steinberg, B.G. Forget, D.R. Higgs & R.L. Nagel), Cambridge. Cambridge University Press, 2001, p. 431-469.
  • 19. Baysal E, Kleanthous M, Bozkunt J, Kyrri A, Kalogirou E, Angastiniots M, Ioannou P and Huisman THJ. α- Thalassemia in the population of Cyprus. 1995; 89:496-499.
  • 20 Chu DHK, Waye JS. Hydrops fetalis caused by α- thalassemia: an emerging heath problem. Blood.1998; 91: 2213-2222.
  • 21. Khoury SA, Massad D. Consanguineous marriages in Jordan.Am Med Genet. 1992; 43: 769-75